Neoplasia/BPH

	Transcriptome-based high-frequency recurrence index predicts frequent recurrence in non-muscle-invasive bladder cancer after Bacillus Calmette-GuÃ©rin therapy. BMC Med Baek SW, Byun YJ, Piao XM, Seo JW, Jeong IS, Kamarov O, Moon S, Kim K, Kang HW, Kim WT, Choi YH, Moon SK, Kim WJ, Choi YD, Kim SY, Kim SK, Yun SJ. PMID: 41749284 [PubMed - as supplied by publisher]
	Re: Durvalumab in combination with BCG for BCG-naive, high risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial. Eur Urol Clark PE. PMID: 41748387 [PubMed - as supplied by publisher]
	Corrigendum to "A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer" [Nanomed Nanotechnol Biol Med 49 (April 2023) 102661]. Nanomedicine Ren S, Dai R, Zheng Z, Liu Q, Zheng X, Li J, Wu S, Zhang R, Gui Z. PMID: 41748385 [PubMed - as supplied by publisher]
	Radiation Therapy Combined with Immunotherapy Before Radical Cystectomy in Locally Advanced Bladder Cancer: A Prospective, Single-arm, Multicenter, Phase 2 Trial (RACE-IT). Eur Urol Oncol Schmid SC, Jahnen M, Schiller K, Sauter A, Seitz AK, Koll F, Wieck F, Korn P, Maisch P, Schwamborn K, Flentje M, Wiegel T, Combs SE, Zengerling F, Bolenz C, Kübler H, Rödel C, Gschwend JE, Retz M, Lewerich J. PMID: 41748359 [PubMed - as supplied by publisher]
	Quantitative PSMA PET Biomarkers for Predicting Response to (177)Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis. J Nucl Med Kiani I, Siri MA, Babaei M, Aliasghari MM, Mohammadzadeh S, Mohammadi S, Salavati A. PMID: 41748296 [PubMed - as supplied by publisher]
	Long-term endocrine sequelae in testicular cancer: clinical manifestations, mechanisms, and follow-up considerations. Actas Urol Esp (Engl Ed) González Beltrán CS, García-Perdomo HA, García Ramos AF. PMID: 41747962 [PubMed - as supplied by publisher]
	Using AI in Forward-Backward Translation of Questionnaires for Men Invited to Prostate Cancer Screening: Methodological Study. JMIR Form Res Andersen SM, Kirkegaard P, Tupikowski K, Hodyra-Stefaniak K, Larsen MB, PRAISE-U Consortium. PMID: 41747240 [PubMed - in process]
	A Cross-Sectional Study Assessing Association of Renal Cell Carcinoma Pathological Grade and Stage With Body Mass Index and Obesity Related Factors. Cancer Control Shrivastava S, Kauffman EC, Wightman P, Kwan ML, Tang L, Langston ME, Deng Z, Lee BR, Chipollini J, Batai K. PMID: 41746625 [PubMed - in process]
	A prescription-free, radiobiology-based framework for automated VMAT planning: A feasibility study in primary prostate cancer radiotherapy. Med Phys Kuhn D, Spohn SKB, Zamboglou C, Grosu AL, Baltas D, Sachpazidis I. PMID: 41746195 [PubMed - in process]
	Breathing-Zone Exposure to Aromatic Volatile Organic Compounds in Surgical Smoke During Transurethral Resection of Bladder Tumor: A Prospective Paired Monitoring Study. Toxics Jo SB, Ahn ST, Oh MM, Shim SH, Ahn CM, Oh SG, Kim JW. PMID: 41745804 [PubMed]
	Indoxyl Sulfate in the Gut-Kidney Axis: Pathophysiology and Clinical Significance in CKD-Associated Colorectal Cancer. Toxins (Basel) Shimizu H, Niwa T. PMID: 41745738 [PubMed - in process]
	MRI-Based Bladder Cancer Staging via YOLOv11 Segmentation and Deep Learning Classification. Diseases Katongtung P, Shiangjen K, Cholamjiak W, Naravejsakul K. PMID: 41745083 [PubMed]
	Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report. Curr Oncol Lewetag RD, Kluthe K, Trautwein NF, Lauer UM, la Fougère C, Sipos B, Zender L, Hinterleitner C, Singer S, Hinterleitner M. PMID: 41744869 [PubMed - in process]
	Historical Perspective of HER2 Testing and Treatment in Prostate Cancer. Curr Oncol Zamalloa N, Rose J, Lap CJ, Rajendran R, Estephan F, Jatwani K, Poudel A, Subrahmanyam R, Hurley PJ, Nava VE, Jain M. PMID: 41744855 [PubMed - in process]
	The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis. Technol Cancer Res Treat Sandeep G, Pahari S, Nayak V, Gundamaraju R, Mishra P, Misra A. PMID: 41744425 [PubMed - in process]
	Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4. J Clin Oncol Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH, Chen DL, Chi KN, Childs DS, Dahut W, Emmett L, Fizazi K, Gafita A, George DJ, Hermann K, Hofman MS, Hope T, Hussain M, Kelly WK, Kessler E, Kuo PH, Lang J, Liu G, Marshall CH, Morgans AK, McKay RR, Nanus D, Nelson P, Paller C, Reichert ZR, Ryan CJ, Sartor AO, Schöder H, Schwartz LH, Sharifi N, Stadler WM, Stein M, Sternberg CN, Szmulewitz RZ, Tagawa ST, Sokolova AO, Wyatt AW, Yamoah K, Yu EY, Halabi S, Scher HI, PCWG4 Writing Group. PMID: 41744290 [PubMed - as supplied by publisher]
	Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026). J Urol Lin DW, Carlsson S, Filson CP, Kim SK, Kirkby E, Konety BR, Purysko AS, Souter LH. PMID: 41744286 [PubMed - as supplied by publisher]
	The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care. BJU Int Sharma A, Campbell T, Kanabar S, Soanes H, Sathanapally G, Bates A, John R, Adams C, Brassill A, Lennon B, Sinha S, Flaxman L, von Hasseln V, Camilleri P, Sabharwal A, Charlton P, Andrade G, Tuthill M, Protheroe A, Lamb AD, Leslie T, Leiblich A, Lopez F, Verrill C, Gleeson F, MacPherson R, Hamdy FC, Bell R, Bryant RJ. PMID: 41744174 [PubMed - as supplied by publisher]
	Preoperative gamma-glutamyl transferase to lymphocyte ratio predicts recurrence in non-muscle-invasive bladder cancer. Front Oncol Zhang X, Su S, Liu L, Song F, Cui X, Cao Y, Li C, Li S, He H, Kang Y, Zhang J. PMID: 41743958 [PubMed]
	Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis. Front Oncol Cui F, Zhang Y, Liu Z, Zhou Y, Man C, Fan Y. PMID: 41743950 [PubMed]

Articles 1 - 20 / 185826

Page 1 of 9292



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy